NIKKI PARKHILL
P HONE : 3-25-660-****
E MAIL : abnt90@r.postjobfree.com
S U M M AR Y
Award winning biotech-pharmaceutical sales representative with consistent national top 10%
ranking for last five years in cardiovascular and pediatric markets in West Texas. Passionate about
providing products and services that make a positive difference in the lives of patients and that are
an asset to customers. Relationship builder who loves to partner with physicians and relevant staff
to remove barriers, create new sales opportunities, and build business.
P R O F E S S I O N AL E X P E R I E N C E
MEDIMMUNE, INC., Gaithersburg, MD 2006 – 2009
Biotech Sales Specialist II
Hired to sell Synagis, an injectible monoclonal antibody that prevents RSV in premature and high
risk infants, and FluMist, an influenza vaccine, in the West Texas market as part of a national
expansion. Managed large rural territory with over 3,000 miles driven monthly and 40-50% travel
requirement. Successfully turned low penetration territory into a leadership area through building
long-term customer loyalty and support. Established strong relationships with distributor/ payors
that facilitated efficient problem resolutions and improved timely access to products. Developed
Brand Coordinators in all offices that provided in-office expertise in patient identification/tracking
and monthly dosing compliance. Utilized new access to TVFC funding to create selling
opportunities in new markets that more than tripled sales and set my territory apart.
SYNAGIS
Earned #1 National Ranking (#1 of 271 reps) with 136% to goal in primary brand
Generated $6.5 million in new business for Synagis in first 2 years in territory
Partnered with distributor to develop and operate a Synagis dosing clinic in rural hospital
where there was previously no access to product. Efforts protected 25 high risk infants
from RSV and generated $250,000 in new business in first season (October to March)
Implemented successful patient identification program in hospitals and offices that pre-
selected and pre-qualified 75% of Synagis candidates prior to dosing season opening date.
Early identification led to meeting 100% of season’s goal in 4th month, with 2 months
remaining, and highest percent to goal attainment in the nation with 136% to goal
Developed compliance program that empowered parents and office coordinators to ensure
monthly dosing was consistently administered over 6 – 7 month period. Implemented
dosing calendars, compliance reminders, and used patient education materials to reduce
monthly no-shows and fall-outs by 85%.
FLUMIST
Earned Top 10% National Ranking (#16 of 271) with 256% to goal in secondary brand
Overcame brand disillusionment and low penetration found in old territory by developing
and consistently targeting key opinion leaders to influence new physicians, making strong
clinical presentations that included product demonstrations, and by targeting all relevant
staff in offices to secure buy-in at each level. Increased sales from initial season of 850
private payor doses to 3780 doses.
2
NIKKI PARKHILL PHONE: 325-***-****
Maximized new sales opportunities with Texas Vaccines for Children. Introduced product
to public health entities, and sold 21,000 doses for 2009-10 VFC projected sales. Efforts
increased total market share from initial of 5% in 2006 to 46% in 2009, (pediatric and family
practice offices) which was #1 in District, and increased number of pediatric offices
offering FluMist from 25% to 95%. Increased awareness created considerably higher
influenza vaccination rate for children in my territory.
Created significant new sales by developing and selling “FluMist in Schools” program, with
Odessa, Texas, schools piloting the project. Started at 1 elementary campus with 900 doses
given and expanded to 9 campuses with 4000 doses utilized during first season. Plans
approved to implement program district wide for 2009-10, with opportunity to provide
protection from influenza for 29,000 students and faculty.
Partnering with school and public health officers, monitored students receiving FluMist in
Odessa schools program for incidence of disease and absenteeism, versus those students
not receiving FluMist, and compared those numbers to previous influenza season.
Experiential study demonstrated marked reduction in disease, significantly fewer missed
school days, and the unexpected positive result of improved standardized test scores for
students who received FluMist. This successful pilot program’s experiential study was
presented at the National Association of School Nurses Convention in Boston, receiving
highest honors there.
PDI, PHARMA, INC., Upper Saddle River, NJ 2003 - 2006
(Contracted with AstraZeneca)
Pharmaceutical Sales Specialist
Hired as part of launch team for new statin, Crestor. Also represented angiotension receptor
blocker, Atacand, and launched new heart failure indication for Atacand. Overcame aggressive
competitors’ marketing activity to successfully launch Crestor in West Texas market. Accomplished
through overcoming objections with strong clinical presentations to physicians and relevant office
staff, gaining access to difficult to see key physicians, and collaborating with national thought leader
advocates to promote the product to territory physicians. Developed nucleus of supporting
physicians who agreed to try Crestor in their practices, then expanded acceptance, building on
positive local experiences and national supportive safety and efficacy data.
CRESTOR
Ranked #1 in Austin District and West Central Business Center Region
Led District and Region in total market share, achieving national goal of 20% market share
first, and consistently winning numerous Regional weekly sales contests
Led campaign to gain and improve access with cardiologists that resulted in highest growth
in market share for that segment in the Region
Organized and conducted team initiatives that increased managed care growth, winning
AstraZeneca awards for highest Rx growth of both Blue Cross Blue Shield and Medicare.
Also identified opportunities and led negotiations with First Care, a major payor in my
market, resulting in inclusion in their formulary.
Successfully negotiated adding Crestor to hospitals’ formularies, despite direct opposition
from competitors. Presented clinical messages to hospital pharmacists and P&T committee
members over a year long period to achieve favorable formulary position.
3
NIKKI PARKHILL PHONE: 325-***-****
ATACAND
Improved market share ranking from 75th of 76 Districts in Region to #1
Recognized consistently at Regional and National levels for continued market share and
new Rx growth, despite brand’s limited formulary access. Achieved success by consistent
messaging, differentiating through clinical comparisons with competitors, implementing
national speaker programs, and demonstrating product’s niche.
OT HER REL EV ANT EX PE R IE NC E
Marketing Representative for psychiatric and chemical dependency hospital
Executive Director for new assisted living center
Program Director for MHMR Vocational Services
S P E C I AL AC H I E V E M E N T S
Selected as presenter for Crestor clinical study at AstraZeneca National Sales Meeting
Produced and presented motivational sales training at Regional Sales Meetings
Recognized 3 times by AstraZeneca managers and peers with “Being the Best Award” for outstanding team
performance (award normally reserved only for AZ sales force)
Received PDI’s “Eagle Award” twice from Regional and District Managers for exceptional team leadership,
and leadership by example (only representative in Southwest Region to receive this award)
E D U C AT I O N
Bachelor’s Degree with double major in Corporate Training and Development, and Business
Administration, with emphasis in Marketing and Management, Abilene Christian University, Abilene, Texas
COMMUN IT Y IN VOLV E ME NT
Board of Directors – March of Dimes
Volunteer – “Loving Care” medical/dental outreach van offering free treatment to local uninsured residents
Volunteer – Chamber of Commerce, special events coordination
Volunteer - United Way – Loaned Executive, fundraiser